CSIR in the news..

An aggregation of news on the web about CSIR and its laboratories

CSIR’s Open Source Drug Discovery is scouting for CROs to pursue advanced study on TB

05 May 2012

BENGALURU: The Council of Scientific and Industrial Research (CSIR)’s ‘Open Source Drug Discovery’ (OSDD) programme is now expanding its drug experimental capabilities. In this regard it is scouting for contract research organizations (CROs) across the country to pursue studies on tuberculosis.

According to officials at the CSIR, there is need to validate and tap the ever increasing computational and experimental leads. The Council is now looking at organizations which have the adequate infrastructure for drug discovery.

Presently tuberculosis is undertaken by AstraZeneca, Lupin, Cipla and Torrent. There are several generic drug players also. TB is the leading cause of death from bacterial infection. WHO reports that one-third of the world’s population is currently infected with the dreaded disease.

According to the World Health Organization, Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000. India ranks second among the 27 MDR-TB high-burden countries worldwide after China….

Read more: http://pharmabiz.com/NewsDetails.aspx?aid=68839&sid=1

Advertisements

Written by csirindia

May 8, 2012 at 5:05 pm

Posted in CSIR

%d bloggers like this: